Author： Edwards I. Ralph
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.33, Iss.2, 2010-02, pp. : 83-86
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Growing support for the Canada Vigilance Program
Reactions Weekly, Vol. 1, Iss. 1299, 2010-01 ,pp. :
Access to resources
Recommend
Aspirin not a wonder drug: careful patient selection important
Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. :
Nitrous oxide: Pneumocephalus leading to vigilance deficit: case report
Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. :
Post-Marketing Surveillance and Vigilance for Medical Devices: The European Approach
By Randall H.
Drug Safety, Vol. 24, Iss. 12, 2001-01 ,pp. :